DKK1 and pancreatic neoplasm: Given that ORI could activate GSK3β activity and up-regulate the expression of DKK1 in human osteosarcoma [41], the anti–migratory effect of ORI on pancreatic cancer cells might result from targeting Wnt/β–catenin signalling.